Pieris Pharmaceuticals Inc (NASDAQ: PIRS) announced that partner AstraZeneca plc (NASDAQ: AZN) decided to discontinue and cease dosing in the ongoing clinical studies of elarekibep, an inhaled IL-4 recepto
15-plus Year SPA Expected to Support Sabine Pass Expansion ProjectCheniere Energy, Inc. ("Cheniere" or the "Company") (NYSE:LNG) announced today that Cheniere's subsidiary, Cheniere Marketing, LLC ("Cheniere Marketing"),
SDA increases satellites in program following budget increase
LOS ANGELES, CA / ACCESSWIRE / June 21, 2023 / Mynaric (NASDAQ:MYNA) (FRA:M0YN), a leading provider of industrialized, cost-effective and scalable
Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress
https://fox59.com/news/politics/ap-politics/pentagon-accounting-error-provides-extra-6-2-billion-for-ukraine-military-aid/
The Pentagon said Tuesday that it overestimated the value of the weapons it has sent to